Senior Director / Executive Director, Small Molecule Chemistry, Late-Stage Development

About the role

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We're looking for people who are determined to make life better for people around the world. Organization and Position Overview: Product Research and Development (PRD) is at the heart of Lilly's R&D engine, helping to turn scientific discoveries into life-changing medicines. With our deep technical and scientific expertise, PRD brings together key R&D teams to get our medicines to patients as quickly and effectively as possible. Our work begins at the start of a medicine's journey, from building a molecule, through developing the right formulation, pioneering patient-friendly drug delivery systems, innovating sustainable manufacturing processes and packaging, supporting clinical trials and finally, helping to get it into the hands of patients. We are there every step of the way. What we do helps make lives better by advancing novel technologies and medicines, speeding up clinical development timelines and reducing costs. Within PRD, Synthetic Molecule Design and Development (SMDD) is an innovation-focused organization striving to identify, develop, and apply transformative technologies to deliver maximum benefit to our patients. We apply our expertise across the entire lifecycle of an asset ranging from the discovery/development interface through regulatory submission and post-approval changes. We work to improve patient outcomes by delivering safe, scalable, sustainable, and reliable products and processes across a diverse portfolio of synthetic assets including small molecules, peptides, and oligonucleotides. The technical and business solutions that we develop accelerate the delivery of medicines to patients and allow the company to reinvest in the next generation of life-saving therapeutics. We are seeking a Senior Director / Executive Director, Small Molecule Chemistry, Late-Stage Development to provide leadership and delivery of the SMDD late-stage small molecule chemistry portfolio. This role will report to the Associate Vice President of Small Molecule Commercialization and be responsible for leading the late-stage small molecule chemistry group, including drug substance process development, scale-up, and commercialization across the late-stage synthetic small molecule portfolio.